Article

Treating cervical cancer: Breast and Cervical Cancer Prevention and Treatment Act patients.

Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
American journal of obstetrics and gynecology (impact factor: 3.28). 03/2011; 204(6):533.e1-8. DOI:10.1016/j.ajog.2011.01.033 pp.533.e1-8
Source: PubMed

ABSTRACT To investigate cervical cancer treatment of patients enrolled under the Breast and Cervical Cancer Prevention and Treatment Act in Georgia.
Georgia Comprehensive Cancer Registry and Medicaid enrollment/claims were used to identify enrollees with preinvasive disease (n = 1149) and invasive cervical cancer (n = 444). Logistic regressions were used to estimate factors associated with the odds of receiving: (1) cancer workup, (2) precancerous procedure, (3) surgery, (4) radiation, and (5) chemotherapy.
Preinvasive disease cases with cervical intraepithelial neoplasia 3, in situ, a comorbidity or without a Commission on Cancer approved hospital nearby were more likely to receive surgery. Among invasive cases, later stage was associated with higher odds of receiving radiation or chemotherapy. Black patients were less likely to have surgery than white patients regardless of preinvasive (P < .01) or invasive status (P = .05).
Treatment patterns among Georgia Medicaid cases appear appropriate to stage but 18% with invasive cervical cancer received no cancer treatment, although Medicaid enrolled.

0 0
 · 
0 Bookmarks
 · 
21 Views

Keywords

appropriate
 
Black patients
 
cancer treatment
 
Cervical Cancer Prevention
 
cervical cancer treatment
 
cervical intraepithelial neoplasia 3
 
estimate factors
 
Georgia Comprehensive Cancer Registry
 
Georgia Medicaid cases
 
higher odds
 
invasive cases
 
invasive cervical cancer
 
invasive status
 
Logistic regressions
 
Medicaid enrollment/claims
 
preinvasive
 
preinvasive disease
 
Preinvasive disease cases
 
Treatment Act
 
white patients
 

Li-Nien Chien